Baloxavir marboxil for reducing direct transmission of influenza A or B in people 5 to 64 years [ID6552]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Baloxavir marboxil for treating and preventing influenza in people 3 weeks to 11 years [ID6554]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC